Q.1
Revenue growth of Sunrest Lifescience Ltd?
Sunrest Lifescience Ltd revenue growth is 12.4% for FY-2025 , which is below its 5 year CAGR of 24.8% , indicating slower growth.
Q.2
Gross Profit margin of Sunrest Lifescience Ltd?
Sunrest Lifescience Ltd Gross profit margin which is the profit after deduction of direct costs, is 8.2% for FY-2025 , which is above its 5 year median of 4.1% , indicating increasing margins.
Q.3
Operating Profit Margin of Sunrest Lifescience Ltd?
Sunrest Lifescience Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 9.06% for FY-2025 , which is above its 5 year median of 4.13% indicating increasing margins.
Q.4
Net Profit Margin of Sunrest Lifescience Ltd?
Sunrest Lifescience Ltd Net Profit Margin is 6.04% for FY-2025 , is above with its 5 year median of 2.89%, indicating increasing margins.
|
Current Level |
Historic Median |
|
Gross Profit Margin |
8.2 |
4.1 |
|
Operating Profit Margin |
9.06 |
4.13 |
|
Net Profit Margin |
6.04 |
2.89 |
Q.5
Return on Asset of Sunrest Lifescience Ltd?
Sunrest Lifescience Ltd Return on Asset is 6.64%, which is in line with its 5 year historical median of 6.64%, indicating stable asset utilization efficiency.
Q.6
Return on Equity (ROE) of Sunrest Lifescience Ltd?
Sunrest Lifescience Ltd Return on equity is 13.17% for FY-2025 , which is below its historical median of 78.01%, indicating the business is making worse use of its shareholders capital.
Q.7
Return on capital employed (ROCE) of Sunrest Lifescience Ltd?
Sunrest Lifescience Ltd Return on capital employed is 13.63% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 14%, indicating value preservation.
Q.8
Cash conversion cycle of Sunrest Lifescience Ltd?
Sunrest Lifescience Ltd Cash conversion cycle is 153 days, above its historical median of 55 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
|
Current Level |
Historic Median |
|
Asset Turnover |
1.1 |
1.66 |
|
ROE |
13.17 |
78.01 |
|
ROCE |
13.63 |
13.63 |
|
Cash Conversion Cycle |
153 days |
55 days |
Q.9
Debt to Equity ratio of Sunrest Lifescience Ltd?
Sunrest Lifescience Ltd Debt-to-Equity ratio is 0.38 , which is above with the industry average of 0.03 , indicating higher debt levels in the industry.
Q.10
Debt to cash flow from operations of Sunrest Lifescience Ltd?
Sunrest Lifescience Ltd Debt to cash flow from operations is 4.32 , which is at a unhealthy level.